By proceeding, you agree to our Terms of Use and Privacy Policy.
This premier marcus evans conference will examine current market and industry challenges such as drug and patient costs, drug and supply shortages, inflationary pressures, securing investment and the cost to develop complex formulations and biosimilars. Additionally, this conference will provide strategies on how to maximize the value and profit margin of portfolios and products in the face of ever-increasing competition and market constraints through partnerships and alliances, licensing strategies, and adopting a patient centric approach.
Dive into nuances of current market and industry challenges such as drug and supply cost and more.
Broaden your spectrum on market growth with the pioneers of the field. Additionally, Interpreting legal pathways to growth for Biosimilars and biologics market penetration.
A deep dipped knowledge on current market and industry challenges such as drug to create portfolio margins and patient costs and become more profitable.
Hear from the industry's big shots and learn to overcome sourcing complexity, cost and shortages to Evolve the business model and maximize profits.
It's been more than 30 years since entrepreneur and Chairman of the Group, Marcus Evans, launched the first of his businesses.
It s been more than 30 years since entrepreneur and Chairman of the Group Marcus Evans launched the first of his businesses Today the Group has grown into one of the world s leading business information companies delivering intelligent and strategic
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.